Orchard Therapeutics | 10-Q: Q3 2023 Earnings Report
Orchard Therapeutics | 8-K: Orchard Therapeutics Reports Third Quarter 2023 Financial Results and Highlights Recent Business Accomplishments
Orchard Therapeutics | 10-Q: Q2 2023 Earnings Report
Orchard Therapeutics | 10-Q: Q1 2023 Earnings Report
Orchard Therapeutics | 8-K: Orchard Therapeutics Reports First Quarter 2023 Financial Results and Announces Initiation of Rolling Submission for Biologics License Application of OTL-200 for Metachromatic Leukodystrophy to U.S. FDA
Orchard Therapeutics | 10-K: FY2022 Annual Report
Orchard Therapeutics | 10-Q: Q3 2022 Earnings Report
Orchard Therapeutics | 8-K: Orchard Therapeutics Reports Third Quarter 2022 Financial Results and Reviews Recent Business Highlights
Orchard Therapeutics | 10-Q: Q2 2022 Earnings Report
Orchard Therapeutics | 8-K: Orchard Therapeutics Reports Second Quarter 2022 Financial Results and Reviews Recent Business Highlights
Orchard Therapeutics | 10-Q: Q1 2022 Earnings Report
Orchard Therapeutics | 8-K: Orchard Therapeutics Reports First Quarter 2022 Financial Results and Highlights Recent Commercial Progress
Orchard Therapeutics | 10-K: FY2021 Annual Report
Orchard Therapeutics | 10-Q: Q3 2021 Earnings Report
Orchard Therapeutics | 10-Q: Q2 2021 Earnings Report
Orchard Therapeutics | 10-Q: Q1 2021 Earnings Report
Orchard Therapeutics | 10-K: FY2020 Annual Report
Orchard Therapeutics | 10-Q: Q3 2020 Earnings Report
Orchard Therapeutics | 10-Q: Q2 2020 Earnings Report
Orchard Therapeutics | 10-Q: Q1 2020 Earnings Report